Checkmate Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Checkmate Pharmaceuticals Ownership

Who owns Checkmate Pharmaceuticals?

Checkmate Pharmaceuticals is owned by Regeneron Pharmaceuticals. It was acquired on April 19, 2022.

Was Checkmate Pharmaceuticals formerly PE-backed?

Yes. Checkmate Pharmaceuticals was formerly owned by 1 private investor.

Checkmate Pharmaceuticals Business Overview

Where is Checkmate Pharmaceuticals headquartered?

Checkmate Pharmaceuticals is headquartered in Cambridge, Massachusetts.

How many employees does Checkmate Pharmaceuticals have?

Checkmate Pharmaceuticals has 25 employees.

What sector is Checkmate Pharmaceuticals in?

Checkmate Pharmaceuticals is a life science company.

When was Checkmate Pharmaceuticals founded?

Checkmate Pharmaceuticals was founded in 2015.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Join Mergr to view all 293 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 256 by strategics.

Checkmate Pharmaceuticals

Checkmate Pharmaceuticals, Inc.

245 Main Street, 2nd Floor,
Cambridge, Massachusetts 02142
United States,
(617) 682-3625
www.checkmatepharma.com

Checkmate Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the activation of innate immunity to treat cancer. Checkmate Pharmaceuticals was formed in 2015 and is based in Cambridge, Massachusetts.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.